Skip to main content
PACSPACS Group, Inc.Sell5.7·$35.89-0.99%
Open full analysis

PACS Group, Inc. (PACS) Stock Analysis

SellVALUE-TRAP 1/5Moderate Confidence

Healthcare · Medical Care Facilities

Sell if holding. Momentum 4.3/10 is below the 5.0 floor at $35.89 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Leverage penalty (D/E 3.4): -1.5; Concentration risk — Geographic: California.

PACS Group is one of the largest skilled nursing facility operators in the US, operating 321 post-acute care facilities across 17 states serving 31,700+ patients daily. Revenue of $5.3B in 2025 comes primarily from Medicare (33.7%) and Medicaid (40.5%) reimbursements; the... Read more

$35.89+19.2% A.UpsideScore 5.7/10#12 of 27 Medical Care Facilities
QualityF-score6 / 9FCF yield5.29%
Stop $33.38Target $42.78(analyst − 13%)A.R:R 2.0:1
Analyst target$49.17+37.0%6 analysts
$42.78our TP
$35.89price
$49.17mean
$52

Sell if holding. Momentum 4.3/10 is below the 5.0 floor at $35.89 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Leverage penalty (D/E 3.4): -1.5; Concentration risk — Geographic: California. Chart setup: No clear chart pattern; technical signals are mixed. Score 5.7/10, moderate confidence.

Passes 6/8 gates (favorable risk/reward ratio, clean insider activity, news events none recent, earnings proximity 55d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum. Suitability: moderate.

10-K grounded · weekly refresh

About PACS Group, Inc.

About PACS Group, Inc.

PACS Group operated 321 post-acute care facilities across 17 states at December 31, 2025, generating $5.3 billion in total revenue for the year — a compound annual growth rate of 30.4% over three years. The portfolio served over 31,700 patients daily, with Mature facilities (150 of 321) averaging a 4.4 QM Star rating and 95% occupancy, compared to the 3.5 Star and 79% occupancy industry averages.

PACS Group earns revenue primarily from Medicare and Medicaid reimbursement, which together accounted for 74.2% of routine revenue in 2025 (33.7% Medicare, 40.5% Medicaid). The company acquires underperforming long-term custodial care SNFs and converts them into higher-acuity, short-term transitional care facilities through an up to three-year post-acquisition transition period. In 2025, Mature facilities generated $2.9 billion in skilled nursing services revenue; Ramping and New facilities contributed $1.1 billion and $1.2 billion, respectively. The portfolio leans heavily on leased properties — 268 of 321 facilities as of December 31, 2025 — with the majority of leased facilities in California; the weighted average annual lease escalator of 2% and average remaining lease term of approximately 13 years provide operational durability. PACS Group competes with other SNF operators for hospital discharge referrals, where its 4.1-Star average portfolio rating versus the 3.5 Star industry average supports admissions mix.

Show full overview

Medicare and Medicaid are set by CMS rate-setting cycles, not negotiated commercially, making them less predictable than private insurance. PACS Group's 10-K identifies changes in patient acuity mix and payor mix as top risks to revenue and financial condition. Any CMS rate reduction for SNF services, or a policy shift favoring home health over facility-based post-acute care, could weigh on the company's blended reimbursement rate. In April 2026, the company appointed Carey Hendrickson as CFO, bringing new financial leadership as the company navigates payer concentration risk.

See also: Healthcare · Medical Care Facilities

From PACS Group, Inc.'s most recent 10-K filing, extracted June 11, 2026.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-06-17
TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Mon, Aug 10, 202655d to earnings· next earnings call

Thesis

Rewards
Strong growth profile
Risks
Concentration risk — Geographic: California
Leverage penalty (D/E 3.4): -1.5
Consecutive earnings misses (2)

Key Metrics

P/E (TTM)23.4
P/E (Fwd)14.4
Mkt Cap$5.7B
EV/EBITDA20.3
Profit Mgn4.5%
ROE27.1%
Rev Growth11.2%
Beta0.00
DividendNone
Rating analysts12

Quality Signals

Piotroski F6/9MoatNarrow

Options Flow

P/C1.33bearish
IV68%elevated
Max Pain$60+67.2% vs spot

Concentration Risks(10-K Item 1A)

  • MEDIUMCustomerMedicare34%
    10-K Item 1: 'Medicare and Medicaid, which represent our largest sources of revenue and accounted for 33.7% and 40.5% of our routine revenue for the year ended December 31, 2025, respectively.'
  • MEDIUMCustomerMedicaid41%
    10-K Item 1: 'Medicare and Medicaid, which represent our largest sources of revenue and accounted for 33.7% and 40.5% of our routine revenue for the year ended December 31, 2025, respectively.'
  • HIGHGeographicCalifornia
    10-K Item 1: 'The majority of these leased facilities are in California'

Material Events(8-K, last 90d)

  • 2026-04-27Item 5.02MEDIUM
    Carey Hendrickson appointed CFO effective April 27, 2026 (successor named, previously CFO at U.S. Physical Therapy). Mark Hancock ceases as Interim CFO but remains Executive Vice Chairman; plans to retire June 30, 2026.
    SEC filing →
  • 2026-03-05Item 5.02LOW
    Patrick H. Conway, MD, MSc appointed to Board as Class III director effective March 4, 2026. No family relationships or related-party transactions disclosed. No reason cited.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

10 dimensions · all in-band

GatesMomentum 4.3<4.5Executive change: officer departure/appointmentA.R:R 2.0 ≥ 1.5Insider activity: OKNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 55d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARSuitability: Moderate
RSI
36 · Neutral
20D MA 50D MA 200D MAGOLDEN CROSSSupport $34.07Resistance $39.62

Price Targets

$33
$43
A.Upside+19.2%
A.R:R2.0:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! momentum at 4.3 (below the engine's 4.5 threshold)

Earnings

B
B
M
M
2/4 beats
Next Earnings2026-08-10 (55d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is PACS stock a buy right now?

Sell if holding. Momentum 4.3/10 is below the 5.0 floor at $35.89 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Leverage penalty (D/E 3.4): -1.5; Concentration risk — Geographic: California. Chart setup: No clear chart pattern; technical signals are mixed. Prior stop was $33.38. Score 5.7/10, moderate confidence.

What is the PACS stock price target?

Take-profit target: $42.78 (+19.2% upside). Prior stop was $33.38. Stop-loss: $33.38.

What are the risks of investing in PACS?

Concentration risk — Geographic: California; Leverage penalty (D/E 3.4): -1.5; Consecutive earnings misses (2).

Is PACS overvalued or undervalued?

PACS Group, Inc. trades at a P/E of 23.4 (forward 14.4). TrendMatrix value score: 6.5/10. Verdict: Sell.

What do analysts say about PACS?

12 analysts cover PACS with a consensus score of 4.3/5. Average price target: $49.

What does PACS Group, Inc. do?PACS Group is one of the largest skilled nursing facility operators in the US, operating 321 post-acute care facilities...

PACS Group is one of the largest skilled nursing facility operators in the US, operating 321 post-acute care facilities across 17 states serving 31,700+ patients daily. Revenue of $5.3B in 2025 comes primarily from Medicare (33.7%) and Medicaid (40.5%) reimbursements; the majority of leased facilities are in California.

Related stocks: AVAH (Aveanna Healthcare Holdings Inc) · THC (Tenet Healthcare Corporation) · UHS (Universal Health Services, Inc.) · ARDT (Ardent Health, Inc.) · EHC (Encompass Health Corporation)
Home Stocks PACS

Latest news

Latest News

Marketscreener.com41d ago
The Globe and Mail49d agoRestructuring
Yahoo Finance50d ago
Msn.com36d ago
富途牛牛43d agoEarnings
Moomoo43d agoEarnings
Bloomingbit40d ago
MSN50d ago
Investing.com Canada51d agoRestructuring
Business Wire51d agoRestructuring
Yahoo Finance51d agoAnalyst
TipRanks36d ago
Marketscreener.com37d agoEarnings
TradingView37d agoEarnings
Marketscreener.com37d ago
Investing.com UK37d agoEarnings
Yahoo Finance37d ago
TipRanks47d agoMerger Acquisition
Investing.com47d agoMerger Acquisition
Investing.com Canada47d agoMerger Acquisition
Loading more...